Hitoshi Hotoda

657 total citations
34 papers, 552 citations indexed

About

Hitoshi Hotoda is a scholar working on Molecular Biology, Infectious Diseases and Organic Chemistry. According to data from OpenAlex, Hitoshi Hotoda has authored 34 papers receiving a total of 552 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 10 papers in Infectious Diseases and 10 papers in Organic Chemistry. Recurrent topics in Hitoshi Hotoda's work include DNA and Nucleic Acid Chemistry (17 papers), HIV/AIDS drug development and treatment (9 papers) and Advanced biosensing and bioanalysis techniques (8 papers). Hitoshi Hotoda is often cited by papers focused on DNA and Nucleic Acid Chemistry (17 papers), HIV/AIDS drug development and treatment (9 papers) and Advanced biosensing and bioanalysis techniques (8 papers). Hitoshi Hotoda collaborates with scholars based in Japan, Germany and United States. Hitoshi Hotoda's co-authors include Masakatsu Kaneko, Mitsuo Sekine, Tsujiaki Hata, Hidehiko Furukawa, Makoto Koizumi, Masayo Kakuta, Toshinori Agatsuma, Yasunori Muramatsu, Takashi Fukuoka and Kaoru Shimada and has published in prestigious journals such as Nucleic Acids Research, Blood and Biochemistry.

In The Last Decade

Hitoshi Hotoda

34 papers receiving 523 citations

Peers

Hitoshi Hotoda
Larryn W. Peterson United States
Ian D. Starkey United Kingdom
G. A. JACOBS United States
Laurent Bonnac United States
P. F. MISCO United States
Hitoshi Hotoda
Citations per year, relative to Hitoshi Hotoda Hitoshi Hotoda (= 1×) peers Masakatsu Kaneko

Countries citing papers authored by Hitoshi Hotoda

Since Specialization
Citations

This map shows the geographic impact of Hitoshi Hotoda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hitoshi Hotoda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hitoshi Hotoda more than expected).

Fields of papers citing papers by Hitoshi Hotoda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hitoshi Hotoda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hitoshi Hotoda. The network helps show where Hitoshi Hotoda may publish in the future.

Co-authorship network of co-authors of Hitoshi Hotoda

This figure shows the co-authorship network connecting the top 25 collaborators of Hitoshi Hotoda. A scholar is included among the top collaborators of Hitoshi Hotoda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hitoshi Hotoda. Hitoshi Hotoda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hotoda, Hitoshi, et al.. (2013). Postmarketing safety experience with edoxaban in Japan for thromboprophylaxis following major orthopedic surgery. Vascular Health and Risk Management. 9. 593–593. 22 indexed citations
2.
Koga, Tetsufumi, Takashi Fukuoka, Norio Doi, et al.. (2004). Activity of capuramycin analogues against Mycobacterium tuberculosis, Mycobacterium avium and Mycobacterium intracellularein vitro and in vivo. Journal of Antimicrobial Chemotherapy. 54(4). 755–760. 76 indexed citations
3.
Hotoda, Hitoshi, Masakatsu Kaneko, Yasunori Muramatsu, et al.. (2003). Synthesis and antimycobacterial activity of capuramycin analogues. Part 2: acylated derivatives of capuramycin-related compounds. Bioorganic & Medicinal Chemistry Letters. 13(17). 2833–2836. 32 indexed citations
4.
Hotoda, Hitoshi, Masakatsu Kaneko, Yasunori Muramatsu, et al.. (2003). Synthesis and antimycobacterial activity of capuramycin analogues. Part 1: substitution of the azepan-2-one moiety of capuramycin. Bioorganic & Medicinal Chemistry Letters. 13(17). 2829–2832. 45 indexed citations
5.
Hotoda, Hitoshi, et al.. (1999). Molecular Recognition of Adenophostin, a Very Potent Ca2+ Inducer, at the d-myo-Inositol 1,4,5-Trisphosphate Receptor. Biochemistry. 38(29). 9234–9241. 42 indexed citations
6.
Koizumi, Makoto, Hitoshi Hotoda, Hidehiko Furukawa, et al.. (1998). Biologically active oligodeoxyribonucleotides. Part 11: The least phosphate-modification of quadruplex-forming hexadeoxyribonucleotide TGGGAG, bearing 3′- and 5′-end-modification, with anti-HIV-1 activity. Bioorganic & Medicinal Chemistry. 6(12). 2469–2475. 18 indexed citations
7.
Hotoda, Hitoshi, Makoto Koizumi, Masakatsu Kaneko, et al.. (1998). Biologically Active Oligodeoxyribonucleotides. 5. 5‘-End-Substituted d(TGGGAG) Possesses Anti-Human Immunodeficiency Virus Type 1 Activity by Forming a G-Quadruplex Structure. Journal of Medicinal Chemistry. 41(19). 3655–3663. 80 indexed citations
8.
Agatsuma, Toshinori, Kohji Abe, Hidehiko Furukawa, et al.. (1997). Protection of hu-PBL-SCID/beige mice from HIV-1 infection by a 6-mer modified oligonucleotide, R-95288. Antiviral Research. 34(3). 121–130. 11 indexed citations
9.
Koizumi, Makoto, Hitoshi Hotoda, Hidehiko Furukawa, et al.. (1997). Biologically active oligodeoxyribonucleotides—IX.1 Synthesis and anti-HIV-1 activity of hexadeoxyribonucleotides, TGGGAG, bearing 3′- and 5′-end-modification. Bioorganic & Medicinal Chemistry. 5(12). 2235–2243. 36 indexed citations
11.
Hotoda, Hitoshi. (1995). IP3 Receptor-Ligand. 1: Synthesis of Adenophostin A. Tetrahedron Letters. 36(28). 5037–5040. 19 indexed citations
12.
Hotoda, Hitoshi, et al.. (1995). IP3 receptor-ligand. 2: Synthesis and molecular mechanics calculation of adenophostin A.. PubMed. 163–4. 3 indexed citations
13.
Hotoda, Hitoshi, Ryuichi Saito, Mitsuo Sekine, & Tsujiaki Hata. (1990). Synthesis of cytidyl(3'-5')adenosine bearing 2'(3')-O-leucyl ester via a phosphorothioate triester intermediate. Tetrahedron. 46(4). 1181–1190. 6 indexed citations
14.
Hotoda, Hitoshi, Takeshi Wada, Mitsuo Sekine, & Tsujiaki Hata. (1989). Pre−activation strategy for oligodeoxyribonudeotide synthesis using triaryloxydichloro−phosphoranes in the phosphotriester method. Nucleic Acids Research. 17(13). 5291–5306. 5 indexed citations
15.
Wada, Takeshi, et al.. (1989). O-alkyl O-nucleoside 3'-phosphonates as novel starting materials for oligonucleotide synthesis.. PubMed. 27–8. 1 indexed citations
16.
Hotoda, Hitoshi, Takeshi Wada, Mitsuo Sekine, & Tsujiaki Hata. (1987). Tris(2,4,6-tribromophenoxy) dichlorophosphorane: A novel condensing agent for rapid internucleotidic bond formation in the phosphotriester approach. Tetrahedron Letters. 28(15). 1681–1684. 12 indexed citations
17.
Matsuzaki, Junichi, Hitoshi Hotoda, Mitsuo Sekine, et al.. (1986). Self-complementary tetradeoxyribonucleoside triphosphates convenient chemical preparation and spectroscopic studies in solution. Tetrahedron. 42(2). 501–513. 12 indexed citations
18.
Nishimura, Yoshifumi, Chikako Torigoe, Masato Katahira, et al.. (1986). A Raman spectroscopic study on the sequence dependent conformations of DNA oligomers.. PubMed. 195–8. 1 indexed citations
19.
Torigoe, Chikako, Yoshifumi Nishimura, Masamichi Tsuboi, et al.. (1986). A Raman spectroscopic analysis of the sequence-dependent structures of oligo-DNA duplexes: d(CGCG)2, d(GCGC)2, d(GGCC)2, and d(CCGG)2 in aqueous solution. Spectrochimica Acta Part A Molecular Spectroscopy. 42(10). 1101–1106. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026